Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Antibacterial acellular dermal dressing with vascularization inducing capability and preparation method thereof

A decellularized dermis and vascularization technology, applied in medical science, prosthesis, etc., can solve the problems of wound infection, cross-infection risk, and limited application, and achieve the effect of improving the ability of vascularization and promoting the proliferation of endothelial cells

Inactive Publication Date: 2017-04-26
GUANGDONG TAIBAO MEDICAL DEVICE TECH RES INST CO LTD
View PDF6 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, since the acellular dermal matrix is ​​an inactive scaffold material, the vascularization ability is low in use, especially the heterogeneous acellular dermal matrix, another problem encountered in clinical application is how to solve the problem of large tissue or organ implantation The source of nutrition in the body. Obviously, it is impossible to achieve the survival of a large number of living cells in the body without a blood supply. How to solve the problem of insufficient vascularization of the acellular dermal matrix in the application is a breakthrough in the acellular dermal matrix. The key to the bottleneck of clinical application of matrix
In addition, the acellular dermal matrix has no antibacterial ability, and when used as a dressing, it is easily infected by bacteria and causes wound infection, and has the risk of cross infection, which also limits its clinical application as a dressing.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antibacterial acellular dermal dressing with vascularization inducing capability and preparation method thereof
  • Antibacterial acellular dermal dressing with vascularization inducing capability and preparation method thereof
  • Antibacterial acellular dermal dressing with vascularization inducing capability and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] An antibacterial acellular dermal dressing capable of inducing vascularization is composed of acellular dermal matrix, polydopamine, vascular endothelial growth factor (VEGF) and antimicrobial peptide LL37; in parts by weight, it consists of 10 parts of acellular dermal matrix, polydopamine 0.25 parts, 0.01 parts of vascular endothelial growth factor, and 0.1 parts of antimicrobial peptide LL37; the vascular endothelial growth factor (VEGF), antimicrobial peptide LL37 were purchased from Thermo Fisher Scientifi Company of the United States.

Embodiment 2

[0029] An antibacterial acellular dermal dressing capable of inducing vascularization is composed of acellular dermal matrix, polydopamine, vascular endothelial growth factor (VEGF) and antimicrobial peptide LL37; in parts by weight, it consists of 10 parts of acellular dermal matrix, polydopamine 0.3 parts of vascular endothelial growth factor, 0.025 parts of vascular endothelial growth factor, and 0.3 parts of antibacterial peptide LL37; the vascular endothelial growth factor (VEGF) and antimicrobial peptide LL37 were purchased from Thermo Fisher Scientifi, USA.

Embodiment 3

[0031]An antibacterial acellular dermal dressing capable of inducing vascularization is composed of acellular dermal matrix, polydopamine, vascular endothelial growth factor (VEGF) and antimicrobial peptide LL37; in parts by weight, it consists of 10 parts of acellular dermal matrix, polydopamine 0.5 parts of vascular endothelial growth factor, 0.05 parts of vascular endothelial growth factor, and antimicrobial peptide LL370.5; the vascular endothelial growth factor (VEGF), antimicrobial peptide LL37 were purchased from Thermo Fisher Scientifi, USA.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of biomedical engineering, in particular relates to the technical field of skin wound dressing preparation, and discloses an antibacterial acellular dermal dressing with vascularization inducing capability and a preparation method thereof. The antibacterial acellular dermal matrix dressing comprises porcine acellular dermal matrix, poly dopamine, vascular endothelial growth factor (VEGF) composition and antibacterial peptide LL37. The antibacterial acellular dermal dressing with the vascularization inducing capability has the advantages of low immunogenicity, good biocompatibility and antibacterial ability, and has obvious wound healing and vascularization promoting effect.

Description

technical field [0001] The invention belongs to the technical field of biomedical engineering, in particular to the technical field of skin wound dressing preparation, and discloses an antibacterial acellular dermal dressing capable of inducing vascularization and a preparation method thereof. Background technique [0002] With the progress of research on the treatment of skin damage, tissue engineered skin has become a research hotspot in recent years and has broad clinical application prospects. When the skin is faced with a large area of ​​burn or damage, it urgently needs to obtain a large amount of epidermal coverage to promote the regeneration and repair of skin tissue. Acellular dermal matrix has many advantages as an ideal skin repair material: (1) cheap and widely sourced; (2) good tissue compatibility, non-toxic and low antigenicity; (3) degradable, The material is gradually absorbed during the degradation process and maintains a stable volume; (4) maintains the c...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61L27/36A61L27/18A61L27/22A61L27/60A61L27/54
CPCA61L27/3633A61L27/18A61L27/227A61L27/54A61L27/60A61L2300/252A61L2300/404A61L2300/414C08L79/02
Inventor 卢亢陈锦涛陈泰瀛
Owner GUANGDONG TAIBAO MEDICAL DEVICE TECH RES INST CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products